The EPO published patent application EP4094724A1 for a prosthetic heart valve on March 25, 2026. The patent application, filed by Edwards Lifesciences Corporation of Irvine, California, names inventors LEVI, SHARONI, SHERMAN, WINTNER, RUPP, NGUYEN, CHADHA, and LINDSTROM. The application is classified under A61F 2/24 (heart valve prostheses) and designates 35 European states including major markets DE, FR, GB, IT, ES, and NL.

Companies developing or commercializing prosthetic heart valve technology in Europe should review this patent publication for potential freedom-to-operate implications. Competitors should assess whether their products fall within the scope of the claims once the application proceeds to grant. Freedom-to-operate opinions may be warranted before launching similar products in designated European markets.